SGLT-2 inhibitor (dapagliflozin) protects against myocardial microcirculation injury induced by ischemia‒reperfusion through limiting NLRP3 inflammasome activation

Research Square 2026 Preprint Open access

Read full text

Authors: Huanchun Ji, Yuanliang Tang, Qinghua Chang, Yuanzhe Jin

DOI: 10.21203/rs.3.rs-8610387/v1

Cited by: 0

Fields of Study & Subjects

Cardiac Ischemia and Reperfusion Inflammasome and immune disorders Cardiac Fibrosis and Remodeling